ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.7393
0.05%
Brent Oil
83.415
-1.10%
Bitcoin
63,411.94
-2.22%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. AMEX
  6. TransEnterix Inc New (TRXC)

  7. TransEnterix Inc New (TRXC) Noticias

TRXC

TransEnterix (TRXC)

TransEnterix Inc New
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:AMEX:TRXC
FechaHoraFuenteTítuloSímboloCompañía
02/03/202005:45Business WireTransEnterix Announces St. Marianna University School of Medicine Toyoko Hospital in Japan to Initiate a Senhance Digital Lap...AMEX:TRXCTransEnterix Inc New
28/02/202006:01Edgar (US Regulatory)Current Report Filing (8-k)AMEX:TRXCTransEnterix Inc New
28/02/202005:55Business WireTransEnterix Announces Kitakyushu General Hospital Completes First Surgical Procedures with the Senhance Surgical SystemAMEX:TRXCTransEnterix Inc New
25/02/202017:16Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:TRXCTransEnterix Inc New
21/02/202016:28Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:TRXCTransEnterix Inc New
14/02/202005:00Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:TRXCTransEnterix Inc New
13/02/202015:35Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)AMEX:TRXCTransEnterix Inc New
12/02/202005:50Business WireTransEnterix Announces CE Mark Approval for Pediatric Indication for Senhance Surgical SystemAMEX:TRXCTransEnterix Inc New
11/02/202015:54Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:TRXCTransEnterix Inc New
10/02/202015:15Business WireTransEnterix Announces Common Stock Purchase Agreement by Lincoln Park Capital Fund, LLCAMEX:TRXCTransEnterix Inc New
10/02/202013:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:TRXCTransEnterix Inc New
07/02/202016:31Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:TRXCTransEnterix Inc New
29/01/202015:05Business WireTransEnterix Announces Kitakyushu General Hospital in Japan to Initiate a Senhance Digital Laparoscopy ProgramAMEX:TRXCTransEnterix Inc New
21/01/202005:55Business WireTransEnterix Announces Klinikum Esslingen to Initiate a Senhance Surgical System ProgramAMEX:TRXCTransEnterix Inc New
14/01/202005:55Business WireTransEnterix Announces Submission of 510(k) to FDA for First Machine Vision System in Robotic SurgeryAMEX:TRXCTransEnterix Inc New
08/01/202005:55Business WireTransEnterix Announces Ochsner Health System to Initiate Program with the Senhance Surgical SystemAMEX:TRXCTransEnterix Inc New
06/01/202017:21Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:TRXCTransEnterix Inc New
06/01/202005:55Business WireTransEnterix Provides 2019 Year End Corporate UpdateAMEX:TRXCTransEnterix Inc New
03/01/202005:55Business WireTransEnterix to Present at the 38th Annual J. P. Morgan Healthcare ConferenceAMEX:TRXCTransEnterix Inc New
02/01/202015:05Business WireTransEnterix, Inc. Announces Appointment of Interim Chief Financial OfficerAMEX:TRXCTransEnterix Inc New
11/12/201910:30Business WireTransEnterix Announces One-for-Thirteen Reverse Stock Split of its Common StockAMEX:TRXCTransEnterix Inc New
26/11/201905:55Business WireTransEnterix, Inc. to Host Surgeon Panel Discussion and Senhance Technology Demonstration Event on Friday, December 6, 2019AMEX:TRXCTransEnterix Inc New
18/11/201908:14Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:TRXCTransEnterix Inc New
12/11/201915:54Edgar (US Regulatory)Quarterly Report (10-q)AMEX:TRXCTransEnterix Inc New
12/11/201915:05Business WireTransEnterix, Inc. Reports Operating and Financial Results for the Third Quarter 2019AMEX:TRXCTransEnterix Inc New
08/11/201915:25Business WireTransEnterix Announces Repayment of Hercules Term Loan and Provides Update on AutoLap TransactionAMEX:TRXCTransEnterix Inc New
08/11/201915:20Business WireTransEnterix Board of Directors Appoints Anthony Fernando as President and Chief Executive OfficerAMEX:TRXCTransEnterix Inc New
06/11/201905:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:TRXCTransEnterix Inc New
31/10/201915:15Business WireTransEnterix Schedules Third Quarter Financial and Operating Results Conference Call for November 12, 2019AMEX:TRXCTransEnterix Inc New
31/10/201901:20Business WireTransEnterix annonce son plan de regroupement d'actionsAMEX:TRXCTransEnterix Inc New
 Showing the most relevant articles for your search:AMEX:TRXC

Su Consulta Reciente

NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
USI
USTECH100
US Tech 100
USOTC
BASFY
BASF (QX)
USOTC
BNPQY
BNP Paribas (QX)
NYSE
JPM
JP Morgan Chase
NASDAQ
TSLA
Tesla
NYSE
AXP
American Express
FX
EURMXN
Euro vs MXN
USOTC
ADDYY
Adidas (QX)
NASDAQ
AMZN
Amazon.com
FX
USDMXN
US Dollar vs MXN
NYSE
XOM
Exxon Mobil
CCOM
US30
US 30
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados